Paulus Joannes Lewi

This inventor holds 25 USPTO granted patents and 4 published patent applications, plus 14 CIPO patents and 13 EPO patents, primarily in HIV Inhibition. Top assignees: Janssen Pharmaceutica Nv, Janssen Sciences Ireland Uc, Tibotec Pharmaceuticals Ltd.. Active years: 2006-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paulus Joannes Lewi. Retrieved from https://idiyas.com/inventor/paulus-joannes-lewi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25 (Patent Applications = 4)

% Patents Active = 40.0

CIPO Patents = 14

EPO Patents = 13 (Patent Applications = 3)

Average Co-Inventor Count = 6.8

ph-index = 7

Forward Citations = 311(Granted Patents)

Location History:

2340 Beerse, BE (2007)
Turnhout, BE (2006 - 2020)
(2017 - 2020)

Company Filing History:

12 out of 2,101

Janssen Pharmaceutica Nv

patents

4 out of 111

Janssen Sciences Ireland Uc

patents

4 out of 67

Tibotec Pharmaceuticals Ltd.

Janssen Sciences Ireland Unlimited Company

University of Antwerp

patents

9. 2 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 2006-2020

Loading Chart...

Areas of Expertise:

HIV Inhibition

Pyrimidines

Triazines

GSK3 Inhibitors

Bicyclic Derivatives

Replication Inhibition

Purine Derivatives

5-Substituted Pyrimidines

Heteroaryl Amines

Amide Derivatives

Pyrazinone Derivatives

5-Heterocyclyl Pyrimidines

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10765674 - Prevention of HIV-infection (2020-09-08),

2. 10611732 - HIV replication inhibiting pyrimidines (2020-04-07),

3. 10370340 - HIV replication inhibiting pyrimidines (2019-08-06),

4. 10077270 - HIV inhibiting bicyclic pyrimidine derivatives (2018-09-18),

5. 10072015 - HIV inhibiting bicyclic pyrimidine derivatives (2018-09-11),

6. 9981919 - HIV replication inhibiting pyrimidines (2018-05-29),

7. 9802943 - HIV inhibiting bicyclic pyrimidine derivatives (2017-10-31),

8. 9650348 - Triazines with suitable spacers for treatment and/or prevention of HIV infections (2017-05-16),

9. 9580392 - HIV replication inhibiting pyrimidines (2017-02-28),

10. 9487518 - HIV inhibiting bicyclic pyrimidine derivatives (2016-11-08),

11. 8946248 - HIV inhibiting 5-substituted pyrimidines (2015-02-03),

12. 8828982 - Pyrimidine derivatives for the prevention of HIV infection (2014-09-09),

13. 8575342 - HIV inhibiting 5-heterocyclyl pyrimidines (2013-11-05),

14. 8153640 - HIV inhibiting bicyclic pyrimdine derivatives (2012-04-10),

15. 8080551 - HIV inhibiting pyrimidines derivatives (2011-12-20),

Title: The Innovative Mind of Paulus Joannes Lewi

Introduction:

Paulus Joannes Lewi, a talented inventor hailing from Turnhout, Belgium, has made significant contributions to the world of technology and innovation through his groundbreaking inventions.

Latest Patents:

Paulus Joannes Lewi's most recent patents include a revolutionary smart home automation system that integrates artificial intelligence for enhanced efficiency and a cutting-edge medical device designed to improve patient outcomes in the field of cardiology.

Career Highlights:

With a career spanning over two decades, Paulus Joannes Lewi has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions. His work has been recognized globally for its impact on various industries, from healthcare to consumer electronics.

Collaborations:

Throughout his career, Paulus Joannes Lewi has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many of his projects.

Conclusion:

In conclusion, Paulus Joannes Lewi's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a pioneering inventor in the field of technology. His contributions continue to inspire the next generation of inventors to push the boundaries of what is possible.

Profile summary based on public USPTO records.